Literature DB >> 3743557

Isolation of Bacteroides strains with reduced sensitivity to 5-nitroimidazoles.

A Dublanchet, J Caillon, J P Emond, H Chardon, H B Drugeon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3743557     DOI： 10.1007/bf02017795

Source DB:  PubMed          Journal:  Eur J Clin Microbiol        ISSN： 0722-2211            Impact factor:   3.267


× No keyword cloud information.
  9 in total

1.  Incomplete anaerobiosis as a cause of metronidazole 'resistance'.

Authors:  S E Milne; E J Stokes; P M Waterworth
Journal:  J Clin Pathol       Date:  1978-10       Impact factor: 3.411

2.  [Appearance of metronidazole resistance in Bacteroides fragilis].

Authors:  H Chardon; A Ratignier; R Luneau; B Garrigues
Journal:  Nouv Presse Med       Date:  1977-06-11

3.  Bacteroides fragilis resistant to metronidazole.

Authors:  M A Eme; J F Acar; F W Goldstein
Journal:  J Antimicrob Chemother       Date:  1983-11       Impact factor: 5.790

4.  Metronidazole-resistant Bacteroides from untreated patient.

Authors:  V O Rotimi; B I Duerden; V Ede; A E MacKinnon
Journal:  Lancet       Date:  1979-04-14       Impact factor: 79.321

5.  Bacteroides fragilis resistant to metronidazole after long-term therapy.

Authors:  H R Ingham; S Eaton; C W Venables; P C Adams
Journal:  Lancet       Date:  1978-01-28       Impact factor: 79.321

6.  ["In vitro" susceptibility of some aerobic and anaerobic bacteria to three 5-nitro-imidazole derivatives: metronidazole, ornidazole and tinidazole (author's transl)].

Authors:  A Dublanchet; R Durieux
Journal:  Ann Microbiol (Paris)       Date:  1980 Jan-Feb

7.  Resistance pattern of anaerobic bacteria isolated in a general hospital during a two-year period.

Authors:  J F Acar; F W Goldstein; M D Kitzis; M T Eyquem
Journal:  J Antimicrob Chemother       Date:  1981-12       Impact factor: 5.790

8.  Light inactivation of metronidazole sensitivity discs.

Authors:  P H Jones; A P Scott
Journal:  J Clin Pathol       Date:  1977-11       Impact factor: 3.411

9.  Antimicrobial susceptibilities of 1,292 isolates of the Bacteroides fragilis group in the United States: comparison of 1981 with 1982.

Authors:  G J Cuchural; F P Tally; N V Jacobus; S L Gorbach; K Aldridge; T Cleary; S M Finegold; G Hill; P Iannini; J P O'Keefe
Journal:  Antimicrob Agents Chemother       Date:  1984-08       Impact factor: 5.191
  9 in total
  6 in total

1.  Survey of the susceptibility patterns of Bacteroides fragilis group strains in France from 1977 to 1992.

Authors:  L Dubreuil; J Breuil; A Dublanchet; A Sedallian
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-11       Impact factor: 3.267

2.  In vitro evaluation of activities of nitazoxanide and tizoxanide against anaerobes and aerobic organisms.

Authors:  L Dubreuil; I Houcke; Y Mouton; J F Rossignol
Journal:  Antimicrob Agents Chemother       Date:  1996-10       Impact factor: 5.191

3.  Detection by PCR of the nim genes encoding 5-nitroimidazole resistance in Bacteroides spp.

Authors:  S Trinh; G Reysset
Journal:  J Clin Microbiol       Date:  1996-09       Impact factor: 5.948

Review 4.  Evolution in antibiotic susceptibility of Bacteroides fragilis group strains in France based on periodic surveys.

Authors:  L Dubreuil; M Derriennic; A Sedallian; C Romond; A L Courtieu
Journal:  Infection       Date:  1989 May-Jun       Impact factor: 3.553

5.  Isolation of metronidazole-resistant Bacteroides fragilis carrying the nimA nitroreductase gene from a patient in Washington State.

Authors:  Jeffrey M Schapiro; Rachna Gupta; Eric Stefansson; Ferric C Fang; Ajit P Limaye
Journal:  J Clin Microbiol       Date:  2004-09       Impact factor: 5.948

Review 6.  Mechanisms of action of systemic antibiotics used in periodontal treatment and mechanisms of bacterial resistance to these drugs.

Authors:  Geisla Mary Silva Soares; Luciene Cristina Figueiredo; Marcelo Faveri; Sheila Cavalca Cortelli; Poliana Mendes Duarte; Magda Feres
Journal:  J Appl Oral Sci       Date:  2012 May-Jun       Impact factor: 2.698
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.